ConvaTec Group PLC (LON:CTEC – Get Free Report) has been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have issued a report on the stock in the last year is GBX 307.17 ($3.86).
A number of brokerages have commented on CTEC. JPMorgan Chase & Co. boosted their price objective on ConvaTec Group from GBX 300 ($3.77) to GBX 323 ($4.06) and gave the stock an “overweight” rating in a research note on Thursday, March 7th. Berenberg Bank boosted their price objective on ConvaTec Group from GBX 290 ($3.64) to GBX 310 ($3.89) and gave the stock a “buy” rating in a research note on Wednesday, March 6th.
Check Out Our Latest Stock Report on CTEC
ConvaTec Group Price Performance
ConvaTec Group Increases Dividend
The business also recently announced a dividend, which will be paid on Thursday, May 23rd. Stockholders of record on Thursday, April 25th will be issued a dividend of $0.04 per share. The ex-dividend date is Thursday, April 25th. This is a positive change from ConvaTec Group’s previous dividend of $0.02. This represents a dividend yield of 1.39%. ConvaTec Group’s dividend payout ratio is 10,000.00%.
About ConvaTec Group
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Recommended Stories
- Five stocks we like better than ConvaTec Group
- Retail Stocks Investing, Explained
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Hilton Demonstrates Asset Light is Right for Investors
- Buy P&G Now, Before It Sets A New All-Time High
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.